Laboratory evolution has generated many biomolecules with desired properties, but a single round of mutation, gene expression, screening or selection, and replication typically requires days or longer with frequent human intervention 1 . Because evolutionary success is dependent on the total number of rounds performed 2 , a means of performing laboratory evolution continuously and rapidly could dramatically enhance its effectiveness 3 . Although researchers have accelerated individual steps in the evolutionary cycle [4] [5] [6] [7] [8] [9] , the only previous example of continuous directed evolution was the landmark study of Wright and Joyce 10 , who continuously evolved RNA ligase ribozymes with an in vitro replication cycle that unfortunately cannot be easily adapted to other biomolecules. Here we describe a system that enables the continuous directed evolution of gene-encoded molecules that can be linked to protein production in Escherichia coli. During phage-assisted continuous evolution (PACE), evolving genes are transferred from host cell to host cell through a modified bacteriophage life cycle in a manner that is dependent on the activity of interest. Dozens of rounds of evolution can occur in a single day of PACE without human intervention. Using PACE, we evolved T7 RNA polymerase (RNAP) variants that recognize a distinct promoter, initiate transcripts with ATP instead of GTP, and initiate transcripts with CTP. In one example, PACE executed 200 rounds of protein evolution over the course of 8 days. Starting from undetectable activity levels in two of these cases, enzymes with each of the three target activities emerged in less than 1 week of PACE. In all three cases, PACE-evolved polymerase activities exceeded or were comparable to that of the wild-type T7 RNAP on its wild-type promoter, representing improvements of up to several hundred-fold. By greatly accelerating laboratory evolution, PACE may provide solutions to otherwise intractable directed evolution problems and address novel questions about molecular evolution.
We devised a system that exploits the continuous culture and selection of the M13 filamentous bacteriophage 11 (commonly used in phage display 12 ) to enable the continuous directed evolution of proteins or nucleic acids. In PACE, E. coli host cells continuously flow through a fixed-volume vessel (the 'lagoon') containing a replicating population of phage DNA vectors ('selection phage') encoding the gene(s) of interest ( Supplementary Fig. 1) .
The average residence time of host cells in the lagoon is less than the time required for E. coli replication. As a result, mutations accumulate only in the evolving selection phage population, the only DNA that can replicate faster than the rate of lagoon dilution. The mutation of host cells in the lagoon should therefore have minimal impact on the outcome of the selection over many rounds of phage replication, and mutagenesis conditions are not limited to those that preserve E. coli viability.
PACE achieves continuous selection by linking the desired activity to the production of infectious progeny phage containing the evolving gene(s). Phage infection requires protein III (pIII; encoded by gene III), which mediates F pilus binding and host cell entry 13 . Phage lacking pIII are approximately 10 8 -fold less infectious than wild-type phage 14 . Crucially, the production of infectious phage scales with increasing levels of pIII over concentrations spanning two orders of magnitude 15 .
To couple pIII production to the activity of interest, we deleted gene III from the phage vector and inserted it into an 'accessory plasmid' present in the E. coli host cells (see Supplementary Fig. 2 for plasmid maps). The production of pIII from the accessory plasmid is dependent on the activity of the evolving gene(s) on the selection phage. Only phage vectors able to induce sufficient pIII production from the accessory plasmid will propagate and persist in the lagoon ( Fig. 1 ). Because pIII expression level determines the rate of infectious phage production 15 , phage encoding genes that result in a higher level of pIII production will infect more host cells than phage encoding less active genes.
Owing to the speed of the phage life cycle (progeny phage production begins approximately 10 min after infection) 16 , PACE can mediate many generations of selective phage replication in a single day. We observed activity-dependent phage vectors that tolerate lagoon flow rates up to 3.2 volumes per hour ( Supplementary Fig. 3 ), corresponding to an average of 38 phage generations per 24 h (see the Supplementary Information for an analysis). More conservative flow rates of 2.0-2.5 volumes per hour allow 24-30 generations per day and reduce the risk of complete phage loss (washout) during selections. Multiple lagoons can evolve genes in parallel, with each 100 ml lagoon containing approximately 5 3 10 10 host cells selectively replicating active phage variants. Importantly, PACE requires no intervention during evolution and obviates the need to create DNA libraries, transform cells, extract genes or perform DNA cloning steps during each round.
In principle, PACE is capable of evolving any gene that can be linked to pIII production in E. coli. Because a wide variety of functions including DNA binding, RNA binding, protein binding, bond-forming catalysis and a variety of enzyme activities have been linked to the expression of a reporter protein 17, 18 , PACE can be applied to the evolution of many different activities of interest. As examples, we successfully linked protein-protein binding, recombinase activity and RNAP activity to phage infectivity in discrete infection assays by creating variants of the accessory plasmid that associate each of these activities with pIII production (Fig. 2) . PACE applies optimal evolutionary pressure when pIII levels are above the minimal threshold required to prevent phage washout, but below the amount needed to maximize infectious phage production. This window can be shifted by varying the copy number of the accessory plasmid, or by altering the ribosome-binding site (RBS) sequence of gene III to modulate the efficiency with which gene III is expressed ( Supplementary Fig. 4 ).
We constructed an arabinose-inducible mutagenesis plasmid that elevates the error rate during DNA replication in the lagoon by suppressing proofreading 19 and enhancing error-prone lesion bypass (Supplementary Information) 20 . Full induction increased the observed mutagenesis rate by approximately 100-fold, inducing all possible transitions and transversions ( Supplementary Fig. 5 ). This enhanced mutation rate is sufficient to sample all possible single and double mutants of a given phage-encoded sequence in each generation (Supplementary Information), in principle enabling single-mutation fitness valleys to be traversed during PACE.
Bacteriophage T7 RNAP is widely used to transcribe RNA in vitro and in cells. T7 RNAP is highly specific for its promoter sequence (TAATACGACTCACTATA), and exhibits virtually no detectable activity on the consensus promoter of the related bacteriophage T3 (AATTAACCCTCACTAAA, differences underlined) 21, 22 . Despite decades of study and several attempts to engineer the specificity of T7 RNAP towards other promoters 22, 23 including that of T3, a mutant T7 RNAP capable of recognizing the T3 promoter has not been previously reported.
To remove potential interference from evolutionary improvements to the phage vector rather than to T7 RNAP, we propagated a selection phage expressing wild-type T7 RNAP for 3 days on host cells containing an accessory plasmid with the wild-type T7 promoter driving gIII expression. A single plaque presumed to represent vector-optimized Host cells with accessory plasmid and mutagenesis plasmid
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The 'lagoon' Figure 2 | Linkage of three protein activities to pIII production and phage infectivity using three distinct accessory plasmids. E. coli cells containing accessory plasmids encoding conditionally expressed gene III (left) and selection phage were combined with recipient cells. Phage production resulted in colonies with antibiotic resistances conferred by the phage and the recipient cells (right). See Methods for details. a, RNAP activity leads to gene III expression and infection comparable to wild-type phage, whereas selection phage lacking T7 RNAP do not infect. b, Protein-protein interaction between a Gal11p domain tethered to a Zif268 DNA-binding domain and an LGF2a domain fused to RNAP leads to gene III expression and infection. c, Recombinase-catalysed gene inversion induces gene III expression and infection. selection phage contained a single mutation (P314T) in T7 RNAP. We confirmed that the activity of the P314T mutant does not significantly differ from that of wild-type T7 RNAP ( Supplementary Fig. 6 ).
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This starting selection phage failed to propagate on host cells containing the T3 promoter accessory plasmid. We therefore propagated the phage on cells containing a hybrid T7/T3 promoter accessory plasmid with the T7 promoter base at the important 211 position 21 but all other positions changed to their T3 counterparts. Two initially identical lagoons were evolved in parallel on the hybrid promoter accessory plasmid for 60 h, then on the complete T3 promoter accessory plasmid for 48 h, and finally on a high-stringency, very low-copy T3 promoter accessory plasmid for 84 h (Fig. 3a) .
Phage persisted in both lagoons after 8 days of PACE, surviving a net dilution of 10 167 -fold, the equivalent of 555 phage population doublings and 200 rounds of evolution by the average phage. We isolated, sequenced and characterized phage vectors from each lagoon after 48, 108 and 192 h, observing up to 8, 10 and 11 non-silent mutations in single T7 RNAP genes at each time point.
Protein-encoding regions (without upstream promoter sequences) of evolved mutant T7 RNAP genes were subcloned into assay plasmids that quantitatively link transcriptional activity to b-galactosidase expression in cells 24 . We defined the activity of wild-type T7 RNAP on the T7 promoter to be 100%. The starting T7 RNAP exhibited undetectable (,3%) levels of activity on the T3 promoter in these cell-based assays. The assayed mutants exhibited more than 200% activity after 108 h of PACE, and more than 600% activity after high-stringency PACE at 192 h, improvements of more than 200-fold ( Fig. 3b, c) . These results collectively establish the ability of PACE to evolve large changes in enzyme activity and specificity very rapidly with minimal intervention by the researcher.
Several evolved T7 RNAP mutants were also purified and assayed in vitro using radioactive nucleotide incorporation assays. Purified T7 RNAP mutants exhibited activity levels on the T3 promoter in vitro exceeding that of wild-type T7 RNAP on the T7 promoter, representing improvements of up to 89-fold compared with the starting enzyme ( Supplementary Fig. 7) . These results indicate that PACE resulted in large improvements in substrate binding or catalytic rate. Evolved activity improvements were higher in cells than in vitro, suggesting that these enzymes also evolved improvements in features such as expression level, polymerase folding or stability that are specific to the context of the cytoplasm.
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consisting of I4M, G175R, E222K and G542V and changed little thereafter beyond acquiring N748D, a mutation known to enable recognition of the T3 base at the 211 position 21 , after exposure to the full T3 promoter. In contrast, lagoon 2 accessed these mutations more slowly before a different suite of mutations also including N748D became predominant at 108 h, only to be displaced by the same suite of mutations observed in lagoon 1. The presence of several mutations unique to lagoon 2 throughout the experiment suggests that lagoon crosscontamination did not occur. The distinct evolutionary trajectories of the two lagoons before their ultimate convergence upon a common set of mutations highlight the ability of PACE to discover multiple viable pathways to a target activity in parallel experiments. This capability may enable a more in-depth experimental study of protein evolutionary dynamics than can be achieved with conventional directed evolution methods that cannot complete so many rounds of evolution on a practical timescale. T7 RNAP is highly specific for initiation with GTP 25, 26 , significantly limiting its usefulness for the in vitro transcription of RNAs that begin with other nucleotides. As initiation has been described as a mechanistically challenging step in transcription 27 , we next used PACE to evolve T7 RNAP variants capable of initiating transcription with other nucleotides in a template-directed manner. T7 RNAP is known to initiate preferentially with GTP up to several bases downstream of the 11 position if the template is devoid of early guanines in the coding strand 26 . We therefore constructed accessory plasmids in which positions 11 to 16 of the gene III transcript were AAAAAA (iA 6 ) or CCCCCC (iC 6 ).
We used PACE to rapidly evolve variants of T7 RNAP capable of initiating with ATP. In view of previous reports indicating varying degrees of initiation of T7 RNAP with ATP 25,26 , we propagated starting phage in host cells with a high-copy iA 6 accessory plasmid for 24 h, followed by a 30:70 high-copy:very-low-copy mixture of host cells for 12 h (Fig. 4a) . At a dilution rate of 2.5 volumes per hour, phage survived a total dilution of 10 39 -fold and experienced an average of approximately 45 rounds of evolution.
The wild-type enzyme exhibited undetectable initial activity in cells (,3%) on the iA 6 promoter. All six clones isolated after only 36 h of PACE exhibited at least 170% activity on the iA 6 promoter in cell-based assays, while retaining at least 120% activity on the wild-type promoter (Fig. 4b ). Purified variants assayed in vitro exhibited activities on the iA 6 promoter matching that of wild-type T7 RNAP on the T7 promoter ( Supplementary Fig. 8 ). RACE analysis of transcripts produced by the most active clone (A6-36.4) confirmed that this enzyme begins transcripts with the template-directed bases on the iA 6 , iC 6 and wild-type promoters ( Supplementary Fig. 9a ). All six characterized clones contained K93T, S397R and S684Y mutations, whereas three of the six also contained S228A (Supplementary Table 2 ). Residue 397 directly contacts the nascent RNA strand 28 , suggesting a role for S397R in allowing efficient initiation of iA 6 transcripts.
We concurrently evolved T7 RNAP to initiate transcripts with CTP ( Supplementary Fig. 10a ). We observed that wild-type T7 RNAP retains significant activity on the iC 6 promoter (,50%) both in cells and in vitro ( Supplementary Fig. 10b, c) , a surprising observation in view of reports that the enzyme initiates with G at the 12 position if the 11 position is C 25 . Although the high starting activity precluded large improvements, the most active PACE-evolved variants nevertheless exceeded 100% activity on the iC 6 promoter both in cells and in vitro ( Supplementary Fig. 10b, c and Supplementary Results). RACE analysis of transcripts produced by the most active clone (C6-80.9) confirmed that this enzyme begins transcripts with the template-directed bases ( Supplementary Fig. 9b ).
The three PACE experiments executed 45-200 rounds of evolution in 1.5-8 days and yielded T7 RNAP variants with activities on their target promoters or templates that exceeded or matched the activity of the wild-type enzyme transcribing the wild-type T7 promoter both in cells and in vitro. This degree of improvement is especially significant given that, for two of the evolved activities, the starting polymerase exhibited virtually no detectable activity.
The evolved A6-36.4 variant of T7 RNAP can initiate transcription from iC 6 , iA 6 and wild-type templates in a template-directed manner with efficiencies comparable to that of wild-type T7 RNAP initiating with the wild-type template ( Supplementary Fig. 11 ) and sequence fidelity sufficient to mediate the production of functional pIII and LacZ enzyme. These findings suggest that this enzyme, and possibly other PACE-evolved variants, may represent improved, more general T7 RNAPs for routine in vitro and in vivo transcription.
The PACE system can be assembled entirely from a modest collection of commercially available equipment (listed in Supplementary  Table 3 ) and does not require the manufacture of any specialized components. The ability to perform dozens of rounds of evolution each day with minimal researcher involvement implies that PACE is particularly well suited to address problems or questions in molecular evolution that require hundreds to thousands of generations, or the execution of many evolution experiments in parallel. More generally, PACE represents the integration and manipulation of many protein and nucleic acid components in a living system to enable the rapid generation of biomolecules with new activities, a significant example and goal of synthetic biology.
METHODS SUMMARY
Discrete infection assays. Donor culture (2 ml) containing accessory plasmid and selection phage were mixed with 198 ml of F 1 recipient cells and incubated for 1.5 h at 37 uC. Dilutions were plated to select for recipient cells containing selection phage. PACE. E. coli host cells with accessory plasmid and mutagenesis plasmid (see Methods) maintained at 5 3 10 8 cells ml 21 were pumped at 2.0, 2.5 or 3.2 volumes per hour into a fixed-volume lagoon seeded with selection phage. Aliquots were taken regularly. Evolved mutants were isolated as individual plaques and subcloned for cell-based or in vitro activity assays. 
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Transcription assays. Activity in cells was measured using a standard b-galactosidase expression assay 24 . In vitro activity was assessed using a standard radioactive nucleotide incorporation assay 29 with His-tag-purified enzyme variants.
METHODS
General methods. All equipment, reagents, suppliers and relevant catalogue numbers are detailed in Supplementary Table 3 . All PCR reactions were performed with HotStart Phusion II polymerase. Water was purified using a MilliQ water purification system (Millipore). DNA cloning. All vectors were constructed by isothermal assembly cloning. 30 Isothermal assembly buffer (53) contained 3 ml 1 M Tris-HCl pH 7.5, 300 ml 1 M MgCl 2 , 600 ml 10 mM deoxynucleotide triphosphates, 300 ml 1 M dithiothreitol, 1.5 g PEG-8000, 20 mg NAD, and H 2 O to 6 ml. Individual 320 ml aliquots were frozen at 220 uC. Isothermal assembly master mix was prepared by mixing 320 ml 53 buffer with 1 ml T5 exonuclease, 20 ml Phusion polymerase, 160 ml Taq DNA ligase, and H 2 O to 700 ml. Individual 15 ml aliquots in PCR tubes were frozen at 220 uC. DNA fragments to be assembled were PCR-amplified using oligonucleotide primers designed to ensure between 30 and 40 base pairs (bp) of overlap homology with each adjacent fragment. DpnI was added directly to the PCR reactions to remove template DNA, followed by PCR cleanup with MinElute columns according to the manufacturer's protocol. Fragments were assembled by mixing equimolar amounts totalling 5 ml with 15 ml isothermal assembly master mix and incubating at 50 uC for 1 h. Assembly mixtures were directly transformed into NEB Turbo competent cells by heat shock or purified by MinElute columns as described before electroporation.
Plasmids. T7 RNAP-dependent accessory plasmids contained, in order, a strong rrnB terminator, the promoter of interest, a desired RBS, gene III, the bla gene conferring carbenicillin resistance, and either the pUC or SC101 origin of replication. For selection stringency assays, RBS A 5 59-AAGGAGGTAACTCATAG TG-39, RBS B 5 59-AAGGAAATAACTCATAGTG-39 and RBS C 5 59-AAG AAAATAACTCATAGTG-39, where underlined bases represent the start codon of gene III. Reporter plasmids were identical to SC101 accessory plasmids except for the replacement of gene III by full-length lacZ. T7 RNAP selection phage was constructed by replacing all but the last 180 bp of gene III with the gene encoding T7 RNAP in VCSM13 helper phage. The mutagenesis plasmid consisted of dnaQ926, umuD9, umuC and recA730 under control of the araC operon. Expression plasmids used for quantification assays consisted of the cloD13 origin of replication, aadA and the wild-type gene III promoter and RBS driving expression of the evolved T7 RNAP variant. All plasmids used in this work are described in Supplementary Table 1 . Vector maps of representative plasmids are shown in Supplementary Fig. 2 . Bacterial strains. All DNA cloning was performed with Mach1 cells or NEB Turbo cells. Early discrete infection assays and PACE experiments were performed with PirPlus DH10bF9DOT cells. Plaque assays and PACE experiments with T7 RNAP were performed with using E. coli S109 cells derived from DH10B by replacement of the proBA locus with the pir116 allele, as previously described. 31 To our knowledge, this modification was not required for PACE experiments with T7 RNAP. Similarly, the lacI cassette was deleted from the F plasmid and from the chromosome to enable mutagenesis assays. S109 cells were rendered F 1 by conjugation with ER2738. The complete genotype of the resulting strain is F9proA1B1 D(lacIZY) zzf::Tn10(TetR)/ endA1 recA1 galE15 galK16 nupGrpsLDlacIZYA araD139 D(ara,leu)7697 mcrA D(mrr-hsdRMS-mcrBC) proBA::pir116 l -. Discrete infection assays. Discrete (non-continuous) infectivity assays were performed by co-transforming phage bearing antibiotic resistance genes with the appropriate accessory plasmid into competent cells to generate phage donors. For two-hybrid and recombinase experiments, phage-producing cells contained gIII-deleted helper phage, accessory plasmid and selection phagemid. The recombinase used was Hin, a member of the serine resolvase family. Colonies were picked and grown overnight in 23 YT media with both antibiotics. Donor cells (2 ml) were mixed with 198 mL F 1 recipient cells in mid-exponential phase containing an antibiotic resistance gene not found in the donor. Mixtures were incubated at 37 uC for 1.5 h and 20 ml of serial dilutions were spread on plates containing the donor and the recipient antibiotics. Infection was quantified by the number of resulting colonies after incubation at 37 uC overnight. For plaque assays, phage DNA was transformed into electrocompetent cells containing the appropriate accessory plasmid and recovered for 1 h at 37 uC, or simply isolated from a lagoon. Serial dilutions were mixed with 300 ml F 1 recipient cells grown to exponential phase in 14 ml Falcon culture tubes and incubated at 37 uC for 15 min. Top agar (3 ml) (7 g l 21 from Luria-Bertani (LB) broth base) at 50 uC was added to each tube, briefly vortexed and poured onto minimal agar plates incubated at 37 uC for 8 h or overnight to generate plaques. Turbidostat assembly. Assembly followed the schematic shown in Supplementary Fig. 1c . Turbidostats were constructed from BioProbe flasks on magnetic stir plates. Each flask was equipped with a TruCell2 cell density meter held in a GL32 probe holder with compression fitting. GL45 and GL32 septa pierced with needles transferred media to and from the turbidostat through an 8-channel peristaltic pump with Tygon tubing. A needle set at the desired turbidostat volume level pumped excess cells to the waste container. A 0.2 mm filter attached to a 14-gauge needle piercing the septum vented the turbidostat vessel. A two-way valve controlled media flow to the turbidostat, connected such that a closed valve state returned the media to source. The valve opened and closed in response to TruCell2 4-20 mA output processed by a digital panel meter programmed with the desired set point. Panel meters were unlocked according to the instruction manual and programmed to the following settings: Input dc_A, Setup 30_ 10, Config 00000, Filtr 11009, dec.pt ddd.dd, lo in 00.400, lo rd 004.00, hi in 02.000, hi rd 020.00, Alset 00036, deu1h 000.01, deu2h 000.01. The digital panel meter and valve were connected with a solderless breadboard according to the diagram shown in Supplementary Fig. 12 . Lagoons consisted of 100 ml Pyrex bottles with GL45 septa pierced with needles for fluid delivery, a 0.2 mm filter-terminated vent line and a magnetic stir bar. Excess lagoon volume was continually pumped to waste through a waste needle set at the desired lagoon volume. Media preparation. Each 20 l media carboy received 140 g anhydrous potassium phosphate dibasic, 40 g potassium phosphate monobasic, 20 g ammonium sulphate, and 20 ml Tween 80 in 20 l H 2 O. Carboys were loosely capped with Polyvent filling/ venting closures with an autoclavable 0.2 mm filter fastened to the venting port. Media was autoclaved until visibly boiling (typically 120 min at 30 pounds per square inch (p.s.i.), 121 uC) and allowed to cool overnight. Media supplement was prepared from 90 g glucose, 10 g sodium citrate, 0.25 g anhydrous magnesium sulphate, 10 g casamino acids, 0.15 g tetracycline-HCl, 0.6 g carbenicillin, 0.6 g spectinomycin and 0.5 g (L)-leucine, dissolved in 500 ml H 2 O, and filtered with a Nalgene 500 ml filtration unit. Media supplement (500 ml) was added to each carboy under conditions that minimized the risk of media contamination (in the case of the reported experiments, immediately after 1 h of germicidal ultraviolet irradiation).
Sterilization and cell culture. The autoclavable components of a turbidostat apparatus include the BioProbe flask, TruCell2 probe, needles, vent filter and tubing. All such components were autoclaved fully assembled except for tubing, which was connected while hot. Upon equilibrating to ambient temperature, the peristaltic pump responsible for media addition and waste removal was started with the valve opened until the desired volume was reached. The TruCell2 probe was connected to its transmitter and zeroed. Turbidostats were seeded with 100 ml of an overnight culture of host cells. Turbidostats and lagoon cultures were grown at 37 uC. Cell density calibration. Serial dilution plating was used to generate a calibration curve to determine TruCell2 output and panel meter setting corresponding to the desired cell density. For these experiments, both panel meter alarms were programmed to open the valve at 6.80 mA. Cells were pumped from the turbidostat to the lagoons by peristaltic pumps with silicone (platinum) two-stop tubing. Calibration curves relating pump speed in revolutions per minute to volumetric flow rate were determined experimentally with a timer and graduated cylinder for each tubing size. PACE experiments. Turbidostats and lagoons were assembled as described above. Upon the turbidostat reaching the desired set point of 6.80 mA (corresponding to 5 3 10 8 cells ml 21 in our hands), lagoons were connected to turbidostats, waste needles were set at the desired volume and lagoon pumps were set to a flow rate corresponding to the desired dilution rate. Each lagoon was seeded with 100 ml of an overnight culture producing selection phage. To induce elevated mutagenesis, 10% filter-sterilized (L)-arabinose was delivered by a separate peristaltic pump to each lagoon requiring enhanced mutagenesis to a final concentration of 1%. Lagoon aliquots were taken by sampling lagoon waste lines at the luer lock just after the peristaltic pump. Individual clones were isolated by plaque assay or amplified by PCR, assembled into a T7 RNAP activity assay plasmid, and transformed into cells containing a lacZ reporter plasmid. Active clones were picked by blue/white screening. Selection phage optimization. T7 RNAP was subcloned into VCSM13 helper phage encoding kanamycin resistance, generating HP-T7RNAP A, used in the discrete infection assay shown in Fig. 2a . To ensure that improvements to the phage genome did not interfere with the evolution of T7 RNAP, HP-T7RNAP A was propagated in a lagoon fed by S109 host cells containing AP-T7 A and DP-QUR and supplemented with arabinose for 72 h at 2.0 volumes per hour. Individual plaques were isolated and their T7 RNAP genes sequenced. One plaque contained only a single point mutation in T7 RNAP, P314T, and was chosen as the preoptimized selection phage for T7 RNAP evolution. Sequencing of the rest of the selection phage revealed numerous changes relative to the parental VCSM13. Notably, the entire p15a-Kan R cassette inserted into the intergenic region to create VCSM13 had been perfectly deleted to reconstitute the wild-type M13 intergenic region. Other changes included N79S, F286S and I360T mutations in gIV, a K249R mutation in gII, three silent mutations back to the corresponding M13 base, two other silent mutations and the deletion of one thymine residue in the terminator before gIII, possibly increasing the expression of T7 RNAP. These regional patterns of variation parallel those observed by Husimi in more extensive filamentous phage evolution RESEARCH LETTER
